Publication | Closed Access

Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children

T PolymorphismHuman RetrovirusGenetic EpidemiologyAntiviral TherapyVirologyCyp2b6 516GPopulation PharmacokineticsAntiviral DrugHivPublic HealthMedicineEpidemiology